These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 36211256)

  • 1. An update on advanced therapies for Parkinson's disease: From gene therapy to neuromodulation.
    Serva SN; Bernstein J; Thompson JA; Kern DS; Ojemann SG
    Front Surg; 2022; 9():863921. PubMed ID: 36211256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European Academy of Neurology/Movement Disorder Society-European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive Therapies.
    Deuschl G; Antonini A; Costa J; Śmiłowska K; Berg D; Corvol JC; Fabbrini G; Ferreira J; Foltynie T; Mir P; Schrag A; Seppi K; Taba P; Ruzicka E; Selikhova M; Henschke N; Villanueva G; Moro E
    Mov Disord; 2022 Jul; 37(7):1360-1374. PubMed ID: 35791767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced Parkinson's disease: clinical characteristics and treatment. Part II.
    Kulisevsky J; Luquin MR; Arbelo JM; Burguera JA; Carrillo F; Castro A; Chacón J; García-Ruiz PJ; Lezcano E; Mir P; Martinez-Castrillo JC; Martínez-Torres I; Puente V; Sesar A; Valldeoriola-Serra F; Yañez R
    Neurologia; 2013; 28(9):558-83. PubMed ID: 23880230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of advanced therapies for Parkinson's disease in Norway.
    Ezat B; Pihlstrøm L; Aasly J; Tysnes OB; Egge A; Dietrichs E
    Tidsskr Nor Laegeforen; 2017 May; 137(9):619-623. PubMed ID: 28468476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Off-time Treatment Options for Parkinson's Disease.
    Fabbri M; Barbosa R; Rascol O
    Neurol Ther; 2023 Apr; 12(2):391-424. PubMed ID: 36633762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromodulation Options and Patient Selection for Parkinson's Disease.
    Rajan R; Skorvanek M; Magocova V; Siddiqui J; AlSinaidi OA; Shinawi HM; AlSubaie F; AlOmar N; Deogaonkar M; Bajwa JA
    Neurol India; 2020; 68(Supplement):S170-S178. PubMed ID: 33318347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application of levodopa/carbidopa intestinal gel in advanced Parkinson's disease].
    Toth A; Nagy H; Wacha J; Bereczki D; Takáts A
    Neuropsychopharmacol Hung; 2015 Dec; 17(4):191-6. PubMed ID: 26727723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalised Advanced Therapies in Parkinson's Disease: The Role of Non-Motor Symptoms Profile.
    Leta V; Dafsari HS; Sauerbier A; Metta V; Titova N; Timmermann L; Ashkan K; Samuel M; Pekkonen E; Odin P; Antonini A; Martinez-Martin P; Parry M; van Wamelen DJ; Ray Chaudhuri K
    J Pers Med; 2021 Aug; 11(8):. PubMed ID: 34442417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of device-based treatments for Parkinson's disease in Germany from 2010 to 2017: application of continuous subcutaneous apomorphine, levodopa-carbidopa intestinal gel, and deep brain stimulation.
    Richter D; Bartig D; Jost W; Jörges C; Stumpe B; Gold R; Krogias C; Tönges L
    J Neural Transm (Vienna); 2019 Jul; 126(7):879-888. PubMed ID: 31222604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinson's Disease: Personalized Pathway of Care for Device-Aided Therapies (DAT) and the Role of Continuous Objective Monitoring (COM) Using Wearable Sensors.
    Metta V; Batzu L; Leta V; Trivedi D; Powdleska A; Mridula KR; Kukle P; Goyal V; Borgohain R; Chung-Faye G; Chaudhuri KR
    J Pers Med; 2021 Jul; 11(7):. PubMed ID: 34357147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalized Medicine in Parkinson's Disease: New Options for Advanced Treatments.
    Mishima T; Fujioka S; Morishita T; Inoue T; Tsuboi Y
    J Pers Med; 2021 Jul; 11(7):. PubMed ID: 34357117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When the going gets tough: how to select patients with Parkinson's disease for advanced therapies.
    Worth PF
    Pract Neurol; 2013 Jun; 13(3):140-52. PubMed ID: 23487815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based review.
    Volkmann J; Albanese A; Antonini A; Chaudhuri KR; Clarke CE; de Bie RM; Deuschl G; Eggert K; Houeto JL; Kulisevsky J; Nyholm D; Odin P; Østergaard K; Poewe W; Pollak P; Rabey JM; Rascol O; Ruzicka E; Samuel M; Speelman H; Sydow O; Valldeoriola F; van der Linden C; Oertel W
    J Neurol; 2013 Nov; 260(11):2701-14. PubMed ID: 23287972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbidopa levodopa enteral suspension.
    Seeberger LC; Hauser RA
    Expert Opin Pharmacother; 2015; 16(18):2807-17. PubMed ID: 26595228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review.
    Wirdefeldt K; Odin P; Nyholm D
    CNS Drugs; 2016 May; 30(5):381-404. PubMed ID: 27138916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson's disease: a multi-country Delphi-panel approach.
    Antonini A; Stoessl AJ; Kleinman LS; Skalicky AM; Marshall TS; Sail KR; Onuk K; Odin PLA
    Curr Med Res Opin; 2018 Dec; 34(12):2063-2073. PubMed ID: 30016901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apomorphine and levodopa infusion therapies for advanced Parkinson's disease.
    Antonini A
    J Mov Disord; 2009 May; 2(1):4-9. PubMed ID: 24868344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translating Evidence to Advanced Parkinson's Disease Patients: A Systematic Review and Meta-Analysis.
    Nijhuis FAP; Esselink R; de Bie RMA; Groenewoud H; Bloem BR; Post B; Meinders MJ
    Mov Disord; 2021 Jun; 36(6):1293-1307. PubMed ID: 33797786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enteral levodopa/carbidopa gel infusion for the treatment of motor fluctuations and dyskinesias in advanced Parkinson's disease.
    Nyholm D
    Expert Rev Neurother; 2006 Oct; 6(10):1403-11. PubMed ID: 17078781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous intra jejunal infusion of levodopa-carbidopa intestinal gel by jejunal extension tube placement through percutaneous endoscopic gastrostomy for patients with advanced Parkinson's disease: a preliminary study.
    Zulli C; Sica M; De Micco R; Del Prete A; Amato MR; Tessitore A; Ferraro F; Esposito P
    Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2413-7. PubMed ID: 27338069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.